Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingjiang Xu

Showing results (91-100 of 139) with videos related to

Pageof 14
Sort By:
Leukemia|November 28, 2023
SRSF2 mutation cooperates with ASXL1 truncated alteration to accelerate leukemogenesisPinpin Sui, Guo Ge, Shi Chen, et al.
Nature Communications|October 31, 2015
Resident c-kit(+) cells in the heart are not cardiac stem cellsNishat Sultana, Lu Zhang, Jianyun Yan, et al.
Leukemia|January 26, 2026
Phf6 truncating mutation drives leukemogenesis via disrupted epigenetic regulation in miceYing Guo, Pinpin Sui, Hui Yang, et al.
JCI Insight|February 23, 2018
Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathwayLakshmi Reddy Palam, Raghuveer Singh Mali, Baskar Ramdas, et al.
Human Molecular Genetics|July 19, 2013
Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient miceRicha Sharma, Xiaohua Wu, Steven D Rhodes, et al.
Cell Discovery|February 10, 2018
Loss of ASXL1 in the bone marrow niche dysregulates hematopoietic stem and progenitor cell fatesPeng Zhang, Zizhen Chen, Rong Li, et al.
Blood|November 21, 2013
Loss of Asxl1 leads to myelodysplastic syndrome-like disease in miceJiapeng Wang, Zhaomin Li, Yongzheng He, et al.
Nature|October 2, 2024
RNA m<sup>5</sup>C oxidation by TET2 regulates chromatin state and leukaemogenesisZhongyu Zou, Xiaoyang Dou, Ying Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2018
<i>IDH1/2</i> Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant InhibitorsRemco J Molenaar, Tomas Radivoyevitch, Yasunobu Nagata, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 29, 2015
Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal HomeostasisSteven D Rhodes, Hao Yang, Ruizhi Dong, et al.
Pageof 14

Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
Leukemia|November 28, 2023
SRSF2 mutation cooperates with ASXL1 truncated alteration to accelerate leukemogenesisPinpin Sui, Guo Ge, Shi Chen, et al.
Nature Communications|October 31, 2015
Resident c-kit(+) cells in the heart are not cardiac stem cellsNishat Sultana, Lu Zhang, Jianyun Yan, et al.
Leukemia|January 26, 2026
Phf6 truncating mutation drives leukemogenesis via disrupted epigenetic regulation in miceYing Guo, Pinpin Sui, Hui Yang, et al.
JCI Insight|February 23, 2018
Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathwayLakshmi Reddy Palam, Raghuveer Singh Mali, Baskar Ramdas, et al.
Human Molecular Genetics|July 19, 2013
Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient miceRicha Sharma, Xiaohua Wu, Steven D Rhodes, et al.
Cell Discovery|February 10, 2018
Loss of ASXL1 in the bone marrow niche dysregulates hematopoietic stem and progenitor cell fatesPeng Zhang, Zizhen Chen, Rong Li, et al.
Blood|November 21, 2013
Loss of Asxl1 leads to myelodysplastic syndrome-like disease in miceJiapeng Wang, Zhaomin Li, Yongzheng He, et al.
Nature|October 2, 2024
RNA m<sup>5</sup>C oxidation by TET2 regulates chromatin state and leukaemogenesisZhongyu Zou, Xiaoyang Dou, Ying Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2018
<i>IDH1/2</i> Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant InhibitorsRemco J Molenaar, Tomas Radivoyevitch, Yasunobu Nagata, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 29, 2015
Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal HomeostasisSteven D Rhodes, Hao Yang, Ruizhi Dong, et al.
Pageof 14